Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BREATHTEK UBT FOR H-PYLORI

UREA C-13

Standard Dose
EQ 75MG/POUCH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BREATHTEK UBT FOR H-PYLORI is listed in Drugs@FDA under application 020586 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient UREA C-13 Form and strength FOR SOLUTION;ORAL - EQ 75MG/POUCH Sponsor OTSUKA AMERICA Submission history Latest submission status date: 2001-05-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview BREATHTEK UBT FOR H-PYLORI is listed in Drugs@FDA under application 020586 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient UREA C-13 Form and strength FOR SOLUTION;ORAL - EQ 75MG/POUCH Sponsor OTSUKA AMERICA Submission history Latest submission status date: 2001-05-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
BREATHTEK UBT FOR H-PYLORI (UREA C-13) | Drug Monograph | MedicHelpline